# Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease

> **NCT00367913** · PHASE4 · COMPLETED · sponsor: **British Thoracic Society** · enrollment: 400 (—)

## Conditions studied

- Pulmonary Diseases

## Interventions

- **DRUG:** Addition of clarithromycin to rifampicin and ethambutol
- **DRUG:** Addition of Ciprofloxacin to rifampicin and ethambutol
- **BIOLOGICAL:** Vaccination with M.vaccae

## Key facts

- **NCT ID:** NCT00367913
- **Lead sponsor:** British Thoracic Society
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-03
- **Primary completion:** —
- **Final completion:** 2004-09
- **Target enrollment:** 400 (—)
- **Last updated:** 2006-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367913, "Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00367913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*